New cocktail of 4 drugs shows promise for Hard-to-Treat myeloma
NCT ID NCT04667663
First seen Apr 23, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This early-phase study tests a combination of four drugs (cyclophosphamide, pomalidomide, dexamethasone, and daratumumab) in 16 people with multiple myeloma that has returned or stopped responding to prior treatments. The main goal is to find the safest dose of the drug pomalidomide when used with the other three. Participants take the drugs in 28-day cycles until the disease worsens or side effects become too severe. This is not a cure, but aims to control the cancer for as long as possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beaumont Hospital
Dublin, Ireland
-
Cork University Hospital
Cork, Ireland
-
Galway University Hospital
Galway, Ireland
Conditions
Explore the condition pages connected to this study.